Arctis Global »

Iovance Biotherapeutics shares owned by Arctis Global

Quarter-by-quarter ownership of Iovance Biotherapeutics (IOVA) shares owned by Arctis Global from 13F filings

Historical chart of Arctis Global investment in Iovance Biotherapeutics

Tip: Access up to 7 years of quarterly data

All positions including Iovance Biotherapeutics held by Arctis Global consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Iovance Biotherapeutics by Arctis Global

Quarter filed Position value Share count Share price at filing
2023-09-30 $397k 87k 4.55

More positions owned by Arctis Global

Ishares Msci Brazil Etf (EWZ)
Select Sector Spdr Tr Energy (XLE)
Ishares Tr Msci Emg Mkt Etf (EEM)
Rekor Systems (REKR)
Spdr Ser Tr S&p Oilgas Exp (XOP)
Teck Resources CL B (TECK)
Global X Fds Global X Uranium (URA)
Pan American Silver Corp Can Call Option (PAAS)
Lockheed Martin Corporation (LMT)
First Horizon National Corporation (FHN)
Ftai Aviation SHS (FTAI)
Atara Biotherapeutics (ATRA)
Iovance Biotherapeutics (IOVA)

View all positions for Arctis Global

Top funds holding Iovance Biotherapeutics

Vanguard Group
MHR Fund Management
Perceptive Advisors
venBio Select Advisor
Artisan Partners Limited Partnership
OrbiMed Advisors
Balyasny Asset Management
Goldman Sachs Group
Dimensional Fund Advisors
T. Rowe Price Associates
Jpmorgan Chase & Co
Credit Suisse
Principal Financial Group
Long Focus Capital Management
Palo Alto Investors

View all funds holding Iovance Biotherapeutics